Shantell Laketa Heiber

Array ( [id] => 6947867 [patent_doc_number] => 20010021501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Mixed cell diagnostic systems' [patent_app_type] => new [patent_app_number] => 09/815829 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19172 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021501.pdf [firstpage_image] =>[orig_patent_app_number] => 09815829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032033 [patent_doc_number] => 20020018765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Diagnosing and treating cancer cells using mutant viruses' [patent_app_type] => new [patent_app_number] => 09/812471 [patent_app_country] => US [patent_app_date] => 2001-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16873 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20020018765.pdf [firstpage_image] =>[orig_patent_app_number] => 09812471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1199378 [patent_doc_number] => 06723324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-20 [patent_title] => 'Chicken anaemia viruses of low pathogenicity' [patent_app_type] => B2 [patent_app_number] => 09/793873 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6636 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723324.pdf [firstpage_image] =>[orig_patent_app_number] => 09793873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375008 [patent_doc_number] => 20020119165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Peptides for inhibition of herpes simplex virus entry' [patent_app_type] => new [patent_app_number] => 09/784887 [patent_app_country] => US [patent_app_date] => 2001-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13747 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119165.pdf [firstpage_image] =>[orig_patent_app_number] => 09784887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1370374 [patent_doc_number] => 06558674 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Polynucleotide vaccine formulation against pathologies of the horse' [patent_app_type] => B1 [patent_app_number] => 09/785055 [patent_app_country] => US [patent_app_date] => 2001-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 8041 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/558/06558674.pdf [firstpage_image] =>[orig_patent_app_number] => 09785055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1350708 [patent_doc_number] => 06576243 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Polynucleotide vaccine formula against porcine reproductive and respiratory pathologies' [patent_app_type] => B1 [patent_app_number] => 09/784984 [patent_app_country] => US [patent_app_date] => 2001-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 25 [patent_no_of_words] => 21031 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576243.pdf [firstpage_image] =>[orig_patent_app_number] => 09784984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6947751 [patent_doc_number] => 20010021385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Human papillomavirus vaccine with disassembled and reassembled virus-like particles' [patent_app_type] => new [patent_app_number] => 09/772365 [patent_app_country] => US [patent_app_date] => 2001-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6528 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021385.pdf [firstpage_image] =>[orig_patent_app_number] => 09772365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6921558 [patent_doc_number] => 20010029043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-11 [patent_title] => 'Attenuated microorganism strains and their uses' [patent_app_type] => new [patent_app_number] => 09/770405 [patent_app_country] => US [patent_app_date] => 2001-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8466 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20010029043.pdf [firstpage_image] =>[orig_patent_app_number] => 09770405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887940 [patent_doc_number] => 20020012670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)' [patent_app_type] => new [patent_app_number] => 09/772316 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 4986 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20020012670.pdf [firstpage_image] =>[orig_patent_app_number] => 09772316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7092869 [patent_doc_number] => 20010034021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2' [patent_app_type] => new [patent_app_number] => 09/758318 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4919 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20010034021.pdf [firstpage_image] =>[orig_patent_app_number] => 09758318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342744 [patent_doc_number] => 06582704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-24 [patent_title] => 'Immunogenic peptides from the HPV E7 protein' [patent_app_type] => B2 [patent_app_number] => 09/759960 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7663 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/582/06582704.pdf [firstpage_image] =>[orig_patent_app_number] => 09759960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7078197 [patent_doc_number] => 20010041175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'Synergistic insect control' [patent_app_type] => new [patent_app_number] => 09/755923 [patent_app_country] => US [patent_app_date] => 2001-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2481 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041175.pdf [firstpage_image] =>[orig_patent_app_number] => 09755923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6729616 [patent_doc_number] => 20030185806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Pluripotent vaccine against enveloped viruses' [patent_app_type] => new [patent_app_number] => 09/751373 [patent_app_country] => US [patent_app_date] => 2000-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 12830 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185806.pdf [firstpage_image] =>[orig_patent_app_number] => 09751373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1466808 [patent_doc_number] => 06458578 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Recombinant cell line produces adenoviral gene products E1 and DEF-A, and/or DEF-B' [patent_app_type] => B1 [patent_app_number] => 09/748044 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5776 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458578.pdf [firstpage_image] =>[orig_patent_app_number] => 09748044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6947749 [patent_doc_number] => 20010021383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Vaccine for mystery swine disease and method for diagnosis thereof' [patent_app_type] => new [patent_app_number] => 09/740156 [patent_app_country] => US [patent_app_date] => 2000-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12677 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021383.pdf [firstpage_image] =>[orig_patent_app_number] => 09740156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1439366 [patent_doc_number] => 06495144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-17 [patent_title] => 'EBNA2 peptides and methods of using same' [patent_app_type] => B2 [patent_app_number] => 09/739852 [patent_app_country] => US [patent_app_date] => 2000-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 12009 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495144.pdf [firstpage_image] =>[orig_patent_app_number] => 09739852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 757350 [patent_doc_number] => 07015016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-21 [patent_title] => 'Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory IgA\'s' [patent_app_type] => utility [patent_app_number] => 10/168115 [patent_app_country] => US [patent_app_date] => 2000-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8927 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015016.pdf [firstpage_image] =>[orig_patent_app_number] => 10168115 [rel_patent_id] =>[rel_patent_doc_number] =>)